Revvity (RVTY) Cash from Investing Activities (2009 - 2026)
Revvity (RVTY) reported Cash from Investing Activities of -$78.3 million for Q2 2026, down 396.87% on a YoY basis from $26.4 million in Q2 2025, and down 318.65% quarter-over-quarter from $35.8 million in Q4 2025.
Revvity (RVTY) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Revvity has reported Cash from Investing Activities for 18 years, with the latest figure at -$78.3 million in Q2 2026.
- For the quarter ending Q2 2026, Cash from Investing Activities fell 396.87% year-over-year to -$78.3 million; the trailing twelve-month figure through Apr 2026 stood at -$79.9 million (down 112.85% YoY), and the FY2025 full-year result was -$17.4 million, down 102.8% from the prior year.
- Cash from Investing Activities for Q2 2026 stood at -$78.3 million, down from $35.8 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $3.9 billion in Q1 2023, with the low at -$556.7 million in Q3 2023.
- Historically, Cash from Investing Activities has averaged $380.0 million across 5 years, with a median of -$18.5 million in 2025.
- Annual changes were most pronounced in 2025 — Cash from Investing Activities soared 120.55% — and 2026, when it sank 396.87%.
- Revvity's Cash from Investing Activities stood at -$48.6 million in 2022, then surged by 3515.56% to $1.7 billion in 2023, then tumbled by 110.5% to -$174.2 million in 2024, then jumped by 120.55% to $35.8 million in 2025, then tumbled by 318.65% to -$78.3 million in 2026.
- The last three Cash from Investing Activities figures came in at -$78.3 million (Q2 2026), $35.8 million (Q4 2025), and -$18.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | -77.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -196.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -32.14 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Revvity | 11.34 Bn | 10.48 Bn | 387.66 Mn | -78.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -78.27 Mn |
| Apr 5, 2026 | -78.27 Mn |
| Dec 28, 2025 | 35.80 Mn |
| Dec 28, 2025 | 35.80 Mn |
| Sep 28, 2025 | -18.53 Mn |
| Sep 28, 2025 | -18.53 Mn |
| Jun 29, 2025 | -18.87 Mn |
| Jun 29, 2025 | -18.87 Mn |
| Mar 30, 2025 | -15.75 Mn |
| Mar 30, 2025 | -15.75 Mn |
| Dec 29, 2024 | -174.23 Mn |
| Dec 29, 2024 | -174.23 Mn |
| Sep 29, 2024 | 837.70 Mn |
| Sep 29, 2024 | 837.70 Mn |
| Jun 30, 2024 | -26.03 Mn |
| Jun 30, 2024 | -26.03 Mn |
| Mar 31, 2024 | -18.18 Mn |
| Mar 31, 2024 | -18.18 Mn |
| Dec 31, 2023 | 1.66 Bn |
| Dec 31, 2023 | 1.66 Bn |